Swiss Life is increasingly leaning on fee-based income, and one analyst believes that could translate into fatter payouts for shareholders in 2027. Berenberg, a German investment bank, estimates that the insurer's fee income rose 8% in the first nine months of 2026, after adjusting for currency swings. That growth, the bank argues, could support stronger cash remittances to the group's holding company next year, with a 1 billion-franc share buyback penciled in for the capital markets day scheduled for December 1, 2027.
Why fee income matters
Fee revenue—such as charges from asset management, financial advice, and other services—typically requires less capital than traditional insurance underwriting. Insurance profits often tie up reserves for years to cover potential claims, but fee income is more predictable and can be converted into cash more easily. That makes it attractive for insurers looking to return money to shareholders through dividends or buybacks.
Berenberg notes that the underlying fee growth was closer to 6% once you exclude the first-time contribution from TELIS Group, a German independent financial adviser network that Swiss Life acquired. That still represents solid momentum, especially in a market where many insurers are trying to pivot toward less capital-intensive business lines.
What the analyst expects
The bank's view is that Swiss Life's fee growth will feed through to higher cash remittances in 2027. In the insurance world, "remittances" refer to the cash that operating subsidiaries send up to the parent company, which can then be used for shareholder returns. A stronger fee base means more of that cash can flow upward without straining the group's capital position.
Berenberg has penciled in a 1 billion-franc buyback for the capital markets day on December 1, 2027. That would be on top of any regular dividends, and it signals confidence that the company can keep generating excess cash. Buybacks are often seen as a positive signal by investors because they reduce the number of shares outstanding, boosting earnings per share and potentially supporting the stock price.
Context: the broader European market
Swiss Life's story comes against a backdrop of European equities performing strongly. The STOXX 600 recently hit a record high as earnings growth powered the region's rally, with insurers among the beneficiaries. Investors have been rewarding companies that can deliver consistent cash generation and shareholder returns, and Swiss Life's fee push fits that narrative.
At the same time, the broader market has been buoyed by optimism around technology and AI, but insurers are a different kind of play—they offer steady, defensive earnings and often attractive yields. For everyday investors, that can make them a useful diversifier, especially when growth stocks look expensive.
What it means for investors
For shareholders, the key takeaway is that Swiss Life appears to be on a path toward higher cash returns. The 8% fee growth, even if partly boosted by the TELIS acquisition, suggests the company's strategy of expanding fee-based services is working. If Berenberg's forecast is right, investors could see a meaningful buyback in 2027, which would likely be welcomed by the market.
However, it's worth noting that analyst forecasts are not guarantees. The actual size and timing of any buyback will depend on how the company's capital position evolves, regulatory requirements, and broader market conditions. Investors should also keep an eye on whether fee growth can be sustained without relying on acquisitions.
For those who already own Swiss Life shares, the news reinforces the case for holding the stock as a source of potential income. For those considering an entry, the prospect of a 1 billion-franc buyback could provide a floor under the share price, but it's always wise to consider the company's valuation and the wider economic environment.
Looking ahead
The capital markets day on December 1, 2027, will be a key event for Swiss Life investors. That's when management is expected to lay out its capital return plans in detail. Until then, the market will be watching quarterly results for signs that fee growth is continuing and that cash remittances are indeed rising.
Berenberg's note adds to a growing chorus of analysts who see Swiss Life as a beneficiary of the shift toward fee-based models in the insurance industry. Whether that translates into sustained shareholder value will depend on execution, but the early signs are encouraging.
